Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 14, 2019 - Issue
Submit an article Journal homepage
110
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD

Yuzo Suzuki1 Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, JapanCorrespondence[email protected]
,
Naoki Inui1 Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan
,
Masato Karayama1 Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan
,
Shiro Imokawa2 Department of Respiratory Medicine, Iwata City Hospital, Iwata, Japan
,
Takashi Yamada3 Department of Respiratory Medicine, Shizuoka City Shizuoka Hospital, Shizuoka, Japan
,
Koushi Yokomura4 Department of Respiratory Medicine, Seirei-Mikatahara Hospital, Hamamatsu, Japan
,
Kazuhiro Asada5 Department of Respiratory Medicine, Shizuoka General Hospital, Shizuoka, Japan
,
Hideki Kusagaya6 Department of Respiratory Medicine, Shizuoka Saiseikai Hospital, Shizuoka, Japan
,
Yusuke Kaida7 Department of Respiratory Medicine, JA Shizuoka Kohseiren Enshu Hospital, Hamamatsu, Japan
,
Hiroyuki Matsuda8 Department of Respiratory Medicine, Shizuoka Red Cross Hospital, Shizuoka, Japan
,
Naoki Koshimizu9 Department of Respiratory Medicine, Fujieda City Hospital, Fujieda, Japan
,
Mikio Toyoshima10 Department of Respiratory Medicine, Hamamatsu Rosai Hospital, Hamamatsu, Japan
,
Masafumi Masuda11 Department of Respiratory Medicine, Shizuoka City Shimizu Hospital, Shizuoka, Japan
,
Hiroshi Hayakawa12 Department of Respiratory Medicine, Tenryu Hospital, National Hospital Organization, Hamamatsu, Japan
,
Hironao Hozumi1 Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan
,
Kazuki Furuhashi1 Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan
,
Noriyuki Enomoto1 Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan
,
Tomoyuki Fujisawa1 Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan
,
Yutaro Nakamura1 Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan
&
Takafumi Suda1 Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan
 show all
Pages 1867-1877 | Published online: 21 Aug 2019

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Chang Qi, Sheng-Wen Sun & Xian-Zhi Xiong. (2022) From COPD to Lung Cancer: Mechanisms Linking, Diagnosis, Treatment, and Prognosis. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2603-2621.
Read now

Articles from other publishers (11)

Joosun Shin, Kord Kober, Melisa L. Wong, Patsy Yates & Christine Miaskowski. (2023) Systematic review of the literature on the occurrence and characteristics of dyspnea in oncology patients. Critical Reviews in Oncology/Hematology 181, pages 103870.
Crossref
Mao Lin, Zongyao Huang, Yingfu Chen, Hongtao Xiao & Ting Wang. (2022) Lung cancer patients with chronic obstructive pulmonary disease benefit from anti-PD-1/PD-L1 therapy. Frontiers in Immunology 13.
Crossref
Carolina Cubillos-Zapata, Elena Díaz-García & Francisco García-Río. 2022. Lung Diseases and Cancer. Lung Diseases and Cancer 1 14 .
Abbas Salihi, Mohammed Al‑Naqshabandi, Zhikal Khudhur, Zjwan Housein, Harmand Hama, Ramyar Abdullah, Bashdar Hussen & Twana Alkasalias. (2022) Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy (Review). Molecular Medicine Reports 26:1.
Crossref
Negar Omidkhah & Razieh Ghodsi. (2022) NO-HDAC dual inhibitors. European Journal of Medicinal Chemistry 227, pages 113934.
Crossref
Hongbin Zhou, Jiuke Li, Zhewen Chen, Ying Chen & Sa Ye. (2021) Nitric oxide in occurrence, progress and therapy of lung Cancer: a systemic review and meta-analysis. BMC Cancer 21:1.
Crossref
Zhao Yang, Rong Yu, Wei Deng & Weihu Wang. (2021) Genetic evidence for the causal association between programmed death-ligand 1 and lung cancer. Journal of Cancer Research and Clinical Oncology 147:11, pages 3279-3288.
Crossref
Inesa Navasardyan & Benjamin Bonavida. (2021) Regulation of T Cells in Cancer by Nitric Oxide. Cells 10:10, pages 2655.
Crossref
Joel Mintz, Anastasia Vedenko, Omar Rosete, Khushi Shah, Gabriella Goldstein, Joshua M. Hare, Ranjith Ramasamy & Himanshu Arora. (2021) Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics. Vaccines 9:2, pages 94.
Crossref
Mitchell S. von Itzstein, Amrit S. Gonugunta, Helen G. Mayo, John D. Minna & David E. Gerber. (2020) Immunotherapy Use in Patients With Lung Cancer and Comorbidities. The Cancer Journal 26:6, pages 525-536.
Crossref
. (2019) Nivolumab. Reactions Weekly 1779:1, pages 179-179.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.